Narjust Florez
MD
Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Apr 02, 2024
Episode
212
Soundcloud
Share
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion on the FLAURA2 study and changes in the first-line treatment of EGFR NSCLC with guests Dr. Pasi Jänne and Dr. Marcelo Corassa. FLAURA2 was first presented at the 2023 WCLC in Singapore by Dr. Jänne.
Guest
Marcelo Corassa
MD
Medical Oncologist and Researcher
A Beneficência Portuguesa de São Paulo
Pasi Janne
MD, PhD
Professor of Medicine
Dana Farber Cancer Institute, Harvard Medical School
